Medication info

Rivoteran Tablets 150 mg (Ranitidine Hydrochloride)

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tablet
Manufacturer / importer
Mirae Bio Pharmaceutical Co., Ltd.
Appearance
Round film-coated tablet, pale yellow to pale beige
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Expired

MFDS item code 199602150 · Notified 1996.03.25

This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of gastric acid-related disorders (such as ulcers), improvement of gastric mucosal lesions, prevention of Mendelson's syndrome
Who takes it
Adults · Children
Adult dose
Administer orally as ranitidine 150 mg twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer this drug orally at 150 mg twice daily, or 300 mg once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The same dosage regimen applies to ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) and to concomitant therapy for preventing gastric or duodenal ulcers during long-term NSAID treatment. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer this drug at 150 mg twice daily for 8 weeks, or 300 mg once daily before bedtime. The dose may be increased to 150 mg 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Begin treatment with an initial dose of 150 mg 3 times daily; the dose may be increased as needed. In severe disease, up to 6 g per day may be administered as directed by a physician. 4) In cases of upper gastrointestinal bleeding due to peptic ulcer, acute stress ulcer, or acute gastric mucosal lesions, treatment is usually initiated with an injectable formulation. Once oral administration is possible, switch to oral administration of this drug at 150 mg twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 150 mg of this drug 2 hours before induction of anesthesia. It is preferable to also administer 150 mg on the evening before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer this drug at 150 mg once daily at bedtime. 7) Hyperacidity, heartburn, and acid regurgitation: In patients 12 years of age and older, administer this drug orally at 75 mg twice daily (liquid formulation only). 3. Patients with renal impairment In patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis decreases the blood concentration of the drug; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.
Child dose
For patients 8 〜 18 years of age, up to 150 mg per dose (2 mg/kg) may be administered twice daily.

Ingredients

Manufacturer
Mirae Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastric acid-related disorders (such as ulcers), improvement of gastric mucosal lesions, prevention of Mendelson's syndrome

  • Gastric and duodenal ulcers
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers caused by the administration of nonsteroidal anti-inflammatory drugs (NSAIDs)
  • gastric mucosal lesions
  • erosion
  • bleeding
  • redness
  • swelling
  • acute gastritis
View approved original text

This medicine is effective in treating gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also used for the prevention of Mendelson syndrome before anesthesia and for ulcers resulting from surgery and nonsteroidal anti-inflammatory drug use. It improves lesions such as erosion, bleeding, redness, and swelling of the gastric mucosa and helps in the treatment of acute exacerbation of acute and chronic gastritis. It can also treat various gastric mucosal injuries associated with upper gastrointestinal bleeding. Moreover, it helps alleviate symptoms of excessive gastric acid, heartburn, and acid regurgitation. It is a medication effective in improving a variety of gastrointestinal diseases and symptoms.

How to take

Adult dose

Administer orally as ranitidine 150 mg twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer this drug orally at 150 mg twice daily, or 300 mg once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The same dosage regimen applies to ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) and to concomitant therapy for preventing gastric or duodenal ulcers during long-term NSAID treatment. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer this drug at 150 mg twice daily for 8 weeks, or 300 mg once daily before bedtime. The dose may be increased to 150 mg 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Begin treatment with an initial dose of 150 mg 3 times daily; the dose may be increased as needed. In severe disease, up to 6 g per day may be administered as directed by a physician. 4) In cases of upper gastrointestinal bleeding due to peptic ulcer, acute stress ulcer, or acute gastric mucosal lesions, treatment is usually initiated with an injectable formulation. Once oral administration is possible, switch to oral administration of this drug at 150 mg twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 150 mg of this drug 2 hours before induction of anesthesia. It is preferable to also administer 150 mg on the evening before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer this drug at 150 mg once daily at bedtime. 7) Hyperacidity, heartburn, and acid regurgitation: In patients 12 years of age and older, administer this drug orally at 75 mg twice daily (liquid formulation only). 3. Patients with renal impairment In patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis decreases the blood concentration of the drug; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.

Child dose

For patients 8 〜 18 years of age, up to 150 mg per dose (2 mg/kg) may be administered twice daily.

Precautions

This medicine should not be used in certain patients. For example, patients with a history of allergy to this drug or its components, or a history of acute porphyria should not take this drug. Additionally, this drug contains lactose, so those with genetic diseases leading to lactose intolerance should not take it. Patients with poor kidney function may have elevated blood concentrations due to insufficient elimination of the drug from the body and should have their dosage reduced or intervals between doses extended. Caution is also necessary for patients with impaired liver function. Patients with a history of drug allergies, elderly patients, and those taking nonsteroidal anti-inflammatory drugs should use this drug cautiously, and especially if there is a history of gastric ulcers, regular examination is necessary. This drug can mask the symptoms of gastric cancer, so patients with gastric ulcers or new or changing dyspeptic symptoms in middle-aged individuals should confirm whether cancer is present before taking this medication. Patients with gastric and duodenal ulcers infected with Helicobacter pylori should also receive treatment to eradicate the bacteria. While taking this medication, very rarely severe allergic reactions such as anaphylactic shock may occur, so if symptoms arise, take the medication immediately and go to the hospital. If symptoms of hypersensitivity such as hives, rash, fever, or breathing difficulties appear, take the medication again immediately. Abnormalities may appear in blood tests such as a decrease in white blood cells or platelets, so if symptoms such as fatigue, bleeding, or fever occur, tests should be conducted, and if necessary, the medication should be discontinued. Symptoms indicating liver dysfunction can occur very rarely; if jaundice or severe fatigue occurs, consult a doctor promptly. Clinical signs of heart rhythm disturbances, constipation, nausea, abdominal pain, confusion, and dizziness can occur very rarely, so careful observation is needed if symptoms develop. This drug can cause various side effects, such as myalgia, arthralgia, and skin rash, so any unusual symptoms should be reported to healthcare professionals immediately. During treatment, the progression of the disease should be closely monitored, and if there is no effect, it is advisable to change to another treatment method. Particularly, special caution should be taken with elderly patients, chronic lung disease patients, diabetes patients, and immunocompromised patients as they may have a higher risk of developing pneumonia. If dizziness or drowsiness occurs after taking this medication, driving or operating dangerous machinery should be avoided. When taking this medication with other drugs, there may be drug interactions, so consult a doctor or pharmacist. Pregnant women or those who may become pregnant should only use this medication when its potential effects on the fetus are fully determined, and only if necessary. Lactating women should also use this medication only when necessary, as it can be transmitted through breast milk. Safety for children has not been sufficiently confirmed, so it should be used cautiously in the pediatric population. Elderly patients may have reduced kidney function, so dosage and intervals should be adjusted accordingly. Some urine tests may yield false-positive results when taking this medication, so care should be taken with testing methods. In cases of overdose, treatment such as vomiting or gastric lavage may be necessary, and in severe cases, blood dialysis can be used to remove the drug. This drug should be kept out of reach of children, and transferring it to another container is not good for maintaining quality. If taken for a prolonged period, it may affect the eyes, so it is advisable to have ophthalmologic check-ups while taking it.

Side effects

  • Anaphylactic shock
  • urticaria
  • angioedema
  • rash
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • elevated serum creatinine levels
Show 57 more
  • leukopenia
  • thrombocytopenia
  • myelosuppression
  • aplastic anemia
  • hypoplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • general fatigue
  • weakness
  • subcutaneous bleeding
  • mucosal bleeding
  • fever
  • liver dysfunction
  • jaundice
  • hepatitis
  • bradycardia
  • heart block
  • tachycardia
  • vasculitis
  • constipation
  • nausea
  • vomiting
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • diarrhea
  • acute pancreatitis
  • dizziness
  • drowsiness
  • convulsions
  • headache
  • heaviness in the head
  • insomnia
  • agitation
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disorders
  • hepatic muscular spasms
  • gynecomastia
  • hyperprolactinemia
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a container that blocks light. Additionally, it is best to store the medication at room temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain the effectiveness and safety of the medication.

Appearance and packaging

Appearance

Round film-coated tablet, pale yellow to pale beige

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.